COMMUNIQUÉS West-GlobeNewswire

Kailera Therapeutics Appoints Doug Pagán as Chief Financial Officer
05/01/2026
— Proven financial and strategic leader with over two decades of experience driving organizational growth, operational excellence, and long‑term value creation — WALTHAM, Mass. and SAN DIEGO, Jan. 05, 2026 (GLOBE [...]
Regional Health Properties, Inc. Completes Additional Repurchases of 12.5% Series B Cumulative Redeemable Preferred Shares
05/01/2026
Atlanta, GA, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Regional Health Properties, Inc. (“Regional”) (OTCQB: RHEP) (OTCQB: RHEPA) (OTCQB: RHEPB) (OTCQB: RHEPZ) today announced it has completed the repurchase of an additional [...]
Corvus Pharmaceuticals Confirms Plans to Announce Results from Cohort 4 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis in January 2026 Following Annual Healthcare Conference
05/01/2026
SOUTH SAN FRANCISCO, Calif., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, confirms the planned announcement of the results from cohort 4 of [...]
FibroBiologics Announces Positive Preclinical Results for a Fibroblast Spheroid-derived Chondrocyte (FSdC) Spheroid Therapy for Degenerative Disc Disease
05/01/2026
FSdC demonstrated statistically significant and superior improvement in disc preservation and structural integrity compared to other treatments HOUSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: [...]
CRISPR Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
ZUG, Switzerland and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today [...]
Caring Brands Announces Exclusive Global License to Manufacture and Market Emesyl
05/01/2026
Jupiter, Fla., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Caring Brands Inc. (Nasdaq: CABR) today announced that it has entered into an exclusive worldwide license agreement with Itonis Inc. to manufacture, market, and [...]
Medera Announces Completion of Patient Enrollment in Cohort B of MUSIC-HFpEF Phase 1/2a Clinical Trial
05/01/2026
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Medera Inc. ("Medera"), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing next-generation therapeutics, today announced that [...]
rYojbaba Issues Letter to Shareholders Detailing 2025 Operational Highlights and 2026 Strategic Priorities
05/01/2026
FUKUOKA, Japan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) (“rYojbaba” or the “Company”) , a Japanese labor consulting and health services company, today issued a letter to its shareholders [...]
Ascendis Pharma to Participate in the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
COPENHAGEN, Denmark, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in the 44 th Annual J.P. Morgan Healthcare Conference and provide a [...]
Xenon to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
VANCOUVER, British Columbia and BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and [...]
Wave Life Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
CAMBRIDGE, Mass., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary
05/01/2026
January 05, 2026 Biodexa Pharmaceuticals PLC Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical [...]
PolarityBio Announces AMA Publication of New Category III CPT Codes for SkinTE® Procedures
05/01/2026
New procedural codes establish standardized pathway for clinical use of autologous heterogeneous skin construct across care settings SALT LAKE CITY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- PolarityBio© , a clinical-stage [...]
Easy Environmental Solutions Announces New Distribution Partnership to Expand Access to Terreplenish®
05/01/2026
MANKATO, Minn., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Easy Environmental Solutions, Inc. (OTC: EZES), the manufacturer of Terreplenish®, a leading organic microbial soil-replenishing technology, today announced a new [...]
Nxera Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
05/01/2026
Tokyo, Japan and Cambridge, UK, 5 January 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that Chris Cargill, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare [...]
Earth Science Tech, Inc. (ETST) Engages Hayden IR, Expanding Investor Relations Efforts to Support its Investor Outreach and Communications
05/01/2026
MIAMI, FL, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company, today announced that it has engaged Hayden IR, a nationally recognized investor [...]
YD Bio Limited Announces Major Milestones and Unveils Robust 2026 Clinical and Commercial Roadmap
05/01/2026
Taipei, Taiwan, Jan. 05, 2026 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic [...]
Alpha Tau Submits First Pre-Market Approval Module to the FDA for Alpha DaRT® for the Treatment of Recurrent Cutaneous Squamous Cell Carcinoma (cSCC)
05/01/2026
- Initial module submission marks an important milestone in the pre-market approval process - - Flexible modular submission framework granted to Alpha Tau by the FDA allows for streamlined review and feedback from the [...]
ProPhase Labs Provides Update on Convertible Debt Conversions, Capital Structure, and Underlying Asset Value
05/01/2026
UNIONDALE, NY, Jan. 05, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. ( OTC: PRPH ) today provided an update to shareholders regarding recent trading activity, its capital structure, and the Company’s underlying asset [...]

Pages